All News

The study was based on 12 years' worth of data from a national survey.

On consecutive days, the FDA announced 2 more strategies to help novel drugs reach more patients. One plan will encourage competition by providing more guidance to developers of complex generics, while the other will make it easier for physicians to treat patients with investigational products through the expanded access program.

The author, who has lived with type 1 diabetes for 16 years, offers practical advice on food, exercise, mindset, and sleep.

Individuals who develop neutropenia are at higher risk of infection, and they should understand the symptoms to look for that might mean they need to seek urgent medical care, explained Ruben A. Mesa, MD, of the Mayo Clinic.

Intuniv, a once-daily non-stimulant from Shire and Shionogi for adults with attention-deficit/hyperactivity disorder, met its primary endpoint and showed a superior change from baseline compared with placebo in a phase 3 study.

October is breast cancer awareness month, and as September ended, a new treatment received the FDA’s approval for advanced breast cancer and another was granted priority review for the adjuvant treatment of early breast cancer.

The filing also seeks new indications for fixed-dose combinations of canagliflozin and metformin.

This is the second year in a row that the prize in Medicine or Physiology has been awarded for work that yielded understanding of chronic disease.

The CEO said the changes will finally allow the company to set the inhaled insulin apart from its rivals.

Skin conditions affect millions of Americans, but patients who seek treatment for their skin condition often face the difficulty of finding an available specialist in their area, according to a new paper published by Derma Care Access Network.

Outreach interventions, including mail outreach invitations, may be effective in increasing the proportion of completed colorectal cancer screening, according to research.

Trust in healthcare is at the lowest level in more than a decade, according to a recent report that surveyed opinions and attitudes of physicians, leaders at hospitals and health systems, insurance company executives, and consumers.

Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease, making it important to assess the risk factors that influence RA so physicians can better treat high-risk patients.

President Donald Trump had clearly been unhappy with the negative press coverage over Price's use of charter flights for routine travel. The HHS Secretary said Thursday he would pay for his seats, or $52,000 of the $400,000 cost of the 26 charter flights taken since May.

Key lessons learnt at the National Comprehensive Cancer Network's policy meeting: Redefining Quality Measurement in Oncology.

Ensuring access to appropriate data and then using the information to improve healthcare outcomes remains an ongoing challenge-this was the conclusion drawn by panelists participating at the National Comprehensive Cancer Network’s Oncology Policy Summit on Redefining Quality Measurement in Oncology.

This week, the top managed care stories included the end of the latest attempt to repeal the Affordable Care Act; a call to better include the patient's voice in cancer quality metrics; and an argument for caution regarding the newly approved CAR T-cell therapy, Kymriah.

Novo Nordisk announced that the FDA has approved its insulin aspart injection Fiasp, which can rapidly improve glycemic control at mealtimes for patients with type 1 and type 2 diabetes.

Not only do patients with cancer incur higher costs when treated in the hospital outpatient setting compared with community oncology practices, they also have higher rates of emergency department visits, according to a recent study.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

After examining over 1000 cases of high-grade gliomas in children and young adults, researchers have split these rare brain tumors into at least 10 different subtypes, which could help clinicians choose and deliver more effective treatments.

A continuous glucose monitor (CGM) device made in the United States is finally approved for use here after patients in 40 other countries already have access.

HHS has challenged mobile app developers and other technology innovators to create an intervention to promote nutrition, health, and fitness among low-income children and families.